Scholars@Duke

Factor V leiden (FVL) mutations and thromboembolic events (TE) in women with breast cancer on adjuvant tamoxifen.

Publication ,  Conference
Garber, JE; Halabi, S; Kaplan, E; Edge, S; Dressler, L; Paskett, E; Berliner, N
Published in: JOURNAL OF CLINICAL ONCOLOGY
June 1, 2005
Link to item

Duke Scholars

Susan Halabi
Author Susan Halabi Biostatistics & Bioinformatics, Division of Biostatistics

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

June 1, 2005

Volume

23

Issue

16

Start / End Page

6S / 6S

Location

Orlando, FL

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

41st Annual Meeting of the American-Society-of-Clinical-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Garber, J. E., Halabi, S., Kaplan, E., Edge, S., Dressler, L., Paskett, E., & Berliner, N. (2005). Factor V leiden (FVL) mutations and thromboembolic events (TE) in women with breast cancer on adjuvant tamoxifen. In JOURNAL OF CLINICAL ONCOLOGY (Vol. 23, pp. 6S-6S). Orlando, FL: AMER SOC CLINICAL ONCOLOGY.
Garber, J. E., S. Halabi, E. Kaplan, S. Edge, L. Dressler, E. Paskett, and N. Berliner. “Factor V leiden (FVL) mutations and thromboembolic events (TE) in women with breast cancer on adjuvant tamoxifen.” In JOURNAL OF CLINICAL ONCOLOGY, 23:6S-6S. AMER SOC CLINICAL ONCOLOGY, 2005.
Garber JE, Halabi S, Kaplan E, Edge S, Dressler L, Paskett E, et al. Factor V leiden (FVL) mutations and thromboembolic events (TE) in women with breast cancer on adjuvant tamoxifen. In: JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2005. p. 6S-6S.
Garber, J. E., et al. “Factor V leiden (FVL) mutations and thromboembolic events (TE) in women with breast cancer on adjuvant tamoxifen.” JOURNAL OF CLINICAL ONCOLOGY, vol. 23, no. 16, AMER SOC CLINICAL ONCOLOGY, 2005, pp. 6S-6S.
Garber JE, Halabi S, Kaplan E, Edge S, Dressler L, Paskett E, Berliner N. Factor V leiden (FVL) mutations and thromboembolic events (TE) in women with breast cancer on adjuvant tamoxifen. JOURNAL OF CLINICAL ONCOLOGY. AMER SOC CLINICAL ONCOLOGY; 2005. p. 6S-6S.

Published In

JOURNAL OF CLINICAL ONCOLOGY

EISSN

1527-7755

ISSN

0732-183X

Publication Date

June 1, 2005

Volume

23

Issue

16

Start / End Page

6S / 6S

Location

Orlando, FL

Publisher

AMER SOC CLINICAL ONCOLOGY

Conference Name

41st Annual Meeting of the American-Society-of-Clinical-Oncology

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences